Catalog No.
YHA43101
Expression system
E. coli
Species
Homo sapiens (Human)
Protein length
Leu24-Glu305
Predicted molecular weight
32.87 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
O15146
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Muscle, skeletal receptor tyrosine-protein kinase, 2.7.10.1, Muscle-specific tyrosine-protein kinase receptor, MuSK, Muscle-specific kinase receptor, MUSK
Comparing functional immune responses in three aquatic turtle species., PMID:40493443
Muscone Reduces OGD/R-Induced Hyperpermeability of the Brain Endothelial Barrier by Activating the PKA/RHOA/MLC Pathway., PMID:40454512
Alleviation of dextran sulfate sodium (DSS)-induced colitis in mice through the antioxidative effects of muscone via the MyD88/p38 MAPK signalling pathway., PMID:40452925
Kisspeptin Receptor Agonists and Antagonists: Strategies for Discovery and Implications for Human Health and Disease., PMID:40430029
The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis., PMID:40422242
The Fusion Protein MuSK-Fc Functions as a Decoy to Block the Binding of Anti-MuSK Antibodies to MuSK., PMID:40411208
Myasthenia gravis with double-seropositive acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies combined with muscle atrophy: a case report and literature review., PMID:40356916
MuSK is a substrate for CaMK2β but this interaction is dispensable for MuSK activation in vivo., PMID:40295530
Agrin/Dok-7-induced JPH2 phosphorylation in muscle cells is involved in AChR clustering., PMID:40290048
Rozanolixizumab for Myasthenia Gravis: a breakthrough treatment and future prospects., PMID:40277145
The blood transcriptome of musk deer under heat stress condition reveals the regulatory mechanism of genes to maintain homeostasis metabolism., PMID:40275126
Lactobacillus salivary LSbg3 is a Potential Food Probiotic Having Excellent Anti-pathogen Effect That Might Improve Antibiotic-Resistant Diarrhea in Dogs., PMID:40259196
[Treatment and clinical course of autoimmune myasthenia in Burkina Faso]., PMID:40248578
Pyridostigmine-induced complete atrioventricular block in a patient with Musk antibody-negative myasthenia gravis a case report : Pyridostigmine-ind advanced AV block in MG patient with MuSK-neg., PMID:40148780
Testing for Acetylcholine Receptor and Muscle-Specific Tyrosine Kinase Antibodies by Fixed Cell-Based Assay in Clinical Practice: Positive Predictive Value for Myasthenia Gravis., PMID:40130472
Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience., PMID:40128464
Naoqing formula alleviates cerebral ischemia/reperfusion injury induced inflammatory injury by regulating Csf3 mediated JAK/STAT pathway and macrophage polarization., PMID:40088744
Clinical Spectrum and Therapeutic Outcome of Myasthenia Gravis in a Tertiary Care Hospital: A Retrospective Study., PMID:40087931
Prevalence and course of muscle-specific receptor tyrosine kinase (MuSK) antibodies in myasthenia gravis - A retrospective study., PMID:40086234
Efficacy and safety of different dosages of rituximab for myasthenia gravis: a single-arm meta-analysis., PMID:40085401
Successful treatment with refractory myasthenia gravis that developed after allogeneic hematopoietic stem cell transplantation: two case reports., PMID:40083543
Development and Application of a Cell-Based Assay for Detecting Anti-Agrin Antibodies Associated With Myasthenia Gravis., PMID:40065451
A Case of Myasthenia Gravis: A Paraneoplastic Syndrome or an Immune-Related Disorder?, PMID:40062097
Double-seropositive Myasthenia Gravis Following COVID-19., PMID:40058857
Single-nuclei sequencing of skeletal muscle reveals subsynaptic-specific transcripts involved in neuromuscular junction maintenance., PMID:40044687
Multiomics analysis provides insights into musk secretion in muskrat and musk deer., PMID:40036429
The protective role of muscone in the development of COPD., PMID:40034710
Extracellular vesicle miRNAs from three-dimensional ovarian cancer in vitro models and their implication in overall cancer survival., PMID:40034306
Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension., PMID:40034001
Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions., PMID:40033991
Unusual presentations of myasthenia gravis and misdiagnosis., PMID:40032968
Physiological roles of ghrelin in the regulation of gastrointestinal motility in vertebrates., PMID:40024446
Efficacy and safety of rituximab in anti-MuSK myasthenia Gravis: a systematic review and meta-analysis., PMID:40021769
Oxidative stress induced by combined glyphosate and TBBPA exposure promotes gill autophagy and inflammation via the PI3K/AKT/mTOR pathway., PMID:40020950
Epigenetic drugs in cancer therapy., PMID:40011240
Young child with MuSK myasthenia gravis: treatment and remission with rituximab., PMID:40000033
Virulence factors and therapeutic methods of Trueperella pyogenes: A review., PMID:39983010
Orbicularis Oculi Stimulated Jitter Analysis in Children With Autoimmune Myasthenia Gravis., PMID:39887421
MuSK Regulates Neuromuscular Junction Nav1.4 Localization and Excitability., PMID:39880682
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial., PMID:39862880
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study., PMID:39862879
Whole Exome Sequencing Reveals Candidate Variants in Ion Channel Genes for Pelvic Muscle Dysfunction in Young Females with a Family History., PMID:39833541
Analysis of Pz-1, a promising therapeutic for organophosphorus poisoning from rodent plasma by liquid chromatography-tandem mass spectrometry., PMID:39793368
Targeted exonic sequencing identifies novel variants in a cerebral small vessel disease cohort., PMID:39743006
Advances in Disease-Modifying Therapeutics for Chronic Neuromuscular Disorders., PMID:39708835
A clinical perspective on muscle specific kinase antibody positive myasthenia gravis., PMID:39703505
Sirtuin Proteins and Memory: A Promising Target in Alzheimer's Disease Therapy?, PMID:39683482
Genome-wide association studies of ischemic stroke based on interpretable machine learning., PMID:39650478
Telitacicept in combination with B-cell depletion therapy in MuSK antibody-positive myasthenia gravis: a case report and literature review., PMID:39624088
McHDV VP60 Virus-like Particles Elicit Protective Immunity Against Moschus chrysogaster Hemorrhagic Disease in Rabbits., PMID:39599478
For research use only. Not for human or drug use.
